This is of particular relevance to HCC, because targeted ablation of cdc42 in mouse hepatocytes and bile ducts resulted in the development of HCC, closely resembling the cancer in Iqgap2 −/− mice in terms of late onset and molecular signature of the tumors [65]. The gene discussed is CDC42; the disease is hepatocellular carcinoma.